Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
随机III期SIERRA试验，比较异基因造血干细胞移植前使用(131)I-阿帕米司单抗与常规治疗复发/难治性急性髓系白血病的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02018
Gyurkocza, Boglarka; Nath, Rajneesh; Seropian, Stuart; Choe, Hannah; Litzow, Mark R; Abboud, Camille; Koshy, Nebu; Stiff, Patrick; Tomlinson, Benjamin; Abhyankar, Sunil; Foran, James; Hari, Parameswaran; Chen, George; Al-Kadhimi, Zaid; Kebriaei, Partow; Sabloff, Mitchell; Orozco, Johnnie J; Jamieson, Katarzyna; Silverman, Margarida; Van Besien, Koen; Schuster, Michael; Law, Arjun Datt; Larkin, Karilyn; Pandit-Taskar, Neeta; Rowley, Scott D; Munshi, Pashna; Cook, Rachel; Levy, Moshe Y; Lazarus, Hillard M; Sandmaier, Brenda M; Pagel, John M; Reddy, Vijay; MacDougall, James; McNamara, Kathleen; Spross, Jennifer; Haeuber, Elaina; Vusirikala, Madhuri; Nahar, Akash; Desai, Avinash; Giralt, Sergio
